Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousHematologic NeoplasmsGraft vs Host DiseaseTransplantation ConditioningStem CellsTissue DonorsBone Marrow TransplantationImmunocompromised HostCytomegalovirus InfectionsOpportunistic InfectionsTransplantationTreatment OutcomePeripheral Blood Stem Cell TransplantationGraft SurvivalHistocompatibilityRetrospective StudiesMycosesWhole-Body IrradiationHematopoiesisKidney TransplantationAspergillosisHematopoietic Stem Cell MobilizationHematologic DiseasesHepatic Veno-Occlusive DiseaseLiver TransplantationTransplantation ChimeraAntigens, CD34Time FactorsLeukemiaCytomegalovirusRecurrenceHistocompatibility TestingCord Blood Stem Cell TransplantationCell TransplantationCell DifferentiationBone Marrow CellsImmunosuppressive AgentsCell LineageAntifungal AgentsFatal OutcomeStem Cell NicheEmbryonic Stem CellsAntiviral AgentsSurvival RateBK VirusAdult Stem CellsBusulfanMesenchymal Stem Cell TransplantationAcute DiseaseSurvival AnalysisHeart TransplantationLymphoproliferative DisordersGraft RejectionMyeloablative AgonistsRisk FactorsMice, Inbred C57BLColony-Forming Units AssayFlow CytometryFollow-Up StudiesFetal BloodChimerismLung TransplantationNeutropeniaMultiple MyelomaCombined Modality TherapyTransplantation ImmunologyIncidenceBone MarrowCells, CulturedOrgan TransplantationAspergillusGraft vs Leukemia EffectProspective StudiesPluripotent Stem CellsMultipotent Stem CellsStem Cell FactorTriazolesNeoplasmsCell SeparationLeukemia, Myeloid, AcuteParamyxoviridae InfectionsGranulocyte Colony-Stimulating FactorRoseolovirus InfectionsSurvivorsRemission InductionHLA AntigensPrognosisImmunosuppressionCell ProliferationAnemia, AplasticMesenchymal Stromal CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositivePolymerase Chain ReactionMyelodysplastic SyndromesMelphalanViral Load